Kong Yun-yi, Dai Bo, Kong Jin-cheng, Zhou Xiao-yan, Lu Hong-fen, Shen Lei, Du Xiang, Shi Da-ren
Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, PR China.
Am J Surg Pathol. 2008 Oct;32(10):1495-502. doi: 10.1097/PAS.0b013e31817a9081.
Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is defined as a rare cytotoxic alpha/beta T-cell lymphoma characterized by primary involvement of subcutaneous tissue mimicking panniculitis and a predominant CD3+/CD4-/CD8+ phenotype in 2005 World Health Organization-European Organization for Research and Treatment of Cancer (WHO-EORTC) classification for cutaneous lymphomas. We presented a detailed study of SPTL, describing clinicopathologic, immunophenotypic, and molecular features of 22 cases in China. Strict diagnostic criteria according to the WHO-EORTC definition were applied to the diagnosis of all SPTL cases. Besides the common features described before, unusual CD4+/CD8- and CD4-/CD8- T-cell phenotypes were noted in 2 of our cases, respectively. CD30 was negative in all cases and CD56 was focally positive in 2 cases. Mortality in cases with angioinvasion (75%) was significantly higher than that in cases without angioinvasion (14.3%). Epstein-Barr virus (EBV) infection was detected in 1 immunocompetent patient by in situ hybridization. The frequency of rearranged TCRB, TCRG, and TCRD genes detected by BIOMED-2 multiplex polymerase chain reaction tubes was 80%, 67%, and 13%, respectively, with a total clonality detection rate of 100%. Clinical follow-up was available in 18 patients, ranging from 6 to 80 months. Most patients obtained complete or partial remission after therapy including one accompanied with EBV infection; 5 patients died: 3 of disease progression, 1 of severe infection, and 1 of complications caused by diabetes and hypertension. We conclude that SPTL as a cytotoxic lymphoma derived from alpha/beta T cell has a predominant CD4-/CD8+ phenotype, but unusual CD4+/CD8- and CD4-/CD8- phenotypes do exist. Owing to its indolent clinical course and relatively high survival rate, SPTL should be differentiated from cutaneous gamma/delta T-cell lymphoma. EBV is generally absent in SPTL but can rarely be detected especially in Asian population. Angioinvasion is a poor prognostic factor in SPTL.
皮下脂膜炎样T细胞淋巴瘤(SPTL)在2005年世界卫生组织-欧洲癌症研究与治疗组织(WHO-EORTC)皮肤淋巴瘤分类中被定义为一种罕见的细胞毒性α/β T细胞淋巴瘤,其特征为主要累及皮下组织,类似脂膜炎,且具有主要的CD3+/CD4-/CD8+表型。我们对SPTL进行了详细研究,描述了中国22例患者的临床病理、免疫表型和分子特征。所有SPTL病例的诊断均采用符合WHO-EORTC定义的严格诊断标准。除了之前描述的常见特征外,我们的病例中有2例分别出现了不寻常的CD4+/CD8-和CD4-/CD8- T细胞表型。所有病例中CD30均为阴性,2例中CD56局灶性阳性。血管侵犯病例的死亡率(75%)显著高于无血管侵犯病例(14.3%)。通过原位杂交在1例免疫功能正常的患者中检测到爱泼斯坦-巴尔病毒(EBV)感染。通过BIOMED-2多重聚合酶链反应管检测到的重排TCRB、TCRG和TCRD基因频率分别为80%、67%和13%,总克隆性检测率为100%。18例患者有临床随访资料,随访时间为6至80个月。大多数患者在接受治疗后获得完全或部分缓解,其中1例伴有EBV感染;5例患者死亡:3例死于疾病进展,1例死于严重感染,1例死于糖尿病和高血压引起的并发症。我们得出结论,SPTL作为一种源自α/β T细胞的细胞毒性淋巴瘤,具有主要的CD4-/CD8+表型,但确实存在不寻常的CD4+/CD8-和CD4-/CD8-表型。由于其临床病程惰性且生存率相对较高,SPTL应与皮肤γ/δ T细胞淋巴瘤相鉴别。EBV在SPTL中通常不存在,但很少能被检测到,尤其是在亚洲人群中。血管侵犯是SPTL的不良预后因素。